Penn Medicine discovery could lead to fewer side effects from a diabetes treatment
A new study details the differences between the two forms of the protein PPARgamma, a target of “glitazone” diabetes drugs, could cut out weight gain side effects.
FULL STORY AT Penn Medicine News →